CDTX (Cidara Therapeutics) Company Cash Volume

Corporate emblem and logo of Cidara Corp (CDTX)

Cidara Therapeutics (CDTX) is implementing the Cloudbreak platform to develop extended-release immunotherapeutic agents. Proprietary hospital drugs ensure stable demand and procurement resilience. Independence from macroeconomic factors renders the asset a defensive asset during a recession. The free cash flow metric demonstrates business liquidity, with the value recorded at 0.40, confirming the company's current solvency.

Cidara Therapeutics Corp - CDTX Company Cash Balance (period 07/04/2022 - 01/17/2026)

Financial and market metric breakdowns for cidara.com (CDTX)

- stock value and consensus price forecast:
Analysis of all company metrics:CDTX Cidara Therapeutics Inc
Brand item of Cidara Therapeutics

Selecting assets with a high margin of safety requires an analysis of liquidity as an absolute indicator of available funds to cover operating expenses. This metric captures the current safety cushion, which is critical for Cidara Therapeutics (CDTX) when financing the development of immunotherapeutic drugs and allocating clinical trial risks, reflecting the trend of physical cash holdings.